Name: Name:1-(4-Bromophenylsulfonyl)-4-methylpiperazine
Brand: AABLOCKS
SKU: AA008IF1
Rating: 90 (10 reviews)

Catalog No.: AA008IF1

837-12-7 | 1-(4-Bromophenylsulfonyl)-4-methylpiperazine

Pack Size： 1g

Purity： 98%

in stock

$62.00 $44.00

Pack Size： 5g

Purity： 98%

in stock

$186.00 $130.00

Pack Size： 25g

Purity： 98%

in stock

$631.00 $442.00

Pack Size： 100g

Purity： 98%

in stock

$2,045.00 $1,432.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA008IF1

Chemical Name: 1-(4-Bromophenylsulfonyl)-4-methylpiperazine

CAS Number: 837-12-7

Molecular Formula: C11H15BrN2O2S

Molecular Weight: 319.2180

MDL Number: MFCD00595522

SMILES: CN1CCN(CC1)S(=O)(=O)c1ccc(cc1)Br

Properties

Complexity: 339

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 17

Hydrogen Bond Acceptor Count: 4

Hydrogen Bond Donor Count: 0

Isotope Atom Count: 0

Rotatable Bond Count: 2

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.6

Downstream Synthesis Route

867333-35-5

837-12-7

7-(2,6-dimethyl-phenyl)-5-methyl-benzo1,2,4triazin-3-yl-4-(4-methyl-piperazine-1-sulfonyl)-phenyl-amine

[1]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.5546-5550

837-12-7

486422-11-1

[1]Patent:WO2011/86531,2011,A2.Locationinpatent:Page/Pagecolumn58-59

[2]Patent:WO2004/55006,2004,A1.Locationinpatent:Page29

[3]Patent:WO2004/55009,2004,A1.Locationinpatent:Page33-34

[4]JournalofMedicinalChemistry,2012,vol.55,p.9107-9119,13

712268-41-2

837-12-7

712268-49-0

[1]Patent:WO2004/52880,2004,A1.Locationinpatent:Page40

837-12-7

73183-34-3

914610-39-2

[1]Patent:WO2012/130299,2012,A1.Locationinpatent:Page/Pagecolumn120

[2]JournalofMedicinalChemistry,2013,vol.56,p.3820-3832

[3]JournalofMedicinalChemistry,2015,vol.58,p.5522-5537

[4]BiochemicalPharmacology,2019,vol.164,p.349-367

[5]JournalofHeterocyclicChemistry,2019,vol.56,p.1260-1274

[6]Patent:WO2005/30770,2005,A1.Locationinpatent:Page/Pagecolumn21

[7]JournalofMedicinalChemistry,2022,vol.65,p.1265-1282

Literature fold

Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Journal: Bioorganic & medicinal chemistry letters20101101

Building Blocks More >

830-78-4

5-Phenyl-1H-1,2,3-triazole-4-carboxylic acid

AA008JYZ | MFCD22053801

81024-42-2

(S)-1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol

AA008L9F | MFCD00869312

79415-18-2

4-Ethylpyridine-2-carboxylic acid hydrochloride

AA008M3Y | MFCD02683327

80352-43-8

Pyridinium, 1-(2-benzothiazolylmethyl)-, iodide

AA008MUD | MFCD01073502

77201-13-9

3-(Piperidin-1-ylcarbonyl)aniline

AA008NJ9 | MFCD00503905

7779-90-0

Zinc phosphate

AA008OAV | MFCD00150399

77529-42-1

3-(4'-BROMO-(1,1'-BIPHENYL)-4-YL)-4-HYDROXY-1H-PYRROLE-2,5-DIONE

AA008OUZ

757251-62-0

4-Chloro-N-methoxy-N-methylpyridine-2-carboxamide

AA008PG7 | MFCD11975556

754193-08-3

N-(4-Amino-2-chlorophenyl)propanamide

AA008Q19 | MFCD03906866

752231-43-9

Ethyl 2-chloro-5-(5-formyl-2-furyl)benzoate

AA008QRN | MFCD01158422